Review in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
31 authors.
Manuel Garrido-RomeroDepartment of Bioactivity and Food Analysis, Instituto de Investigación en Ciencias de la Alimentación (CIAL), CSIC-UAM, CEI (UAM+CSIC), Madrid, Spain.ORCID 0000-0002-6474-4274
Florencio PazosComputational Systems Biology Group, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.ORCID 0000-0002-2646-6226
Elisa Sánchez-MartínezDepartment of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.ORCID 0000-0001-9821-1049
Carlos BenitoInstituto de Gestión de la Innovación y del Conocimiento, INGENIO (CSIC and U. Politécnica de Valencia), Valencia, Spain.ORCID 0000-0002-6702-3317
Gonzalo Borrego-YanizInstitute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain.ORCID 0000-0003-1474-2884
Cameron BowesHealth Canada, Ottawa, ON, Canada.
Hermann BrollDepartment of Food Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.ORCID 0000-0002-3671-8140
Alberto CamineroDepartment of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.ORCID 0000-0001-9555-7167
Mónica ChagoyenComputational Systems Biology Group, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.ORCID 0000-0001-6911-1591
Marianne ChemalyFrench Agency for Food, Environmental and Occupational Health and Safety, ANSES, Hygiene and Quality of Poultry, Pig Products Unit, Ploufragan, France.ORCID 0000-0002-8432-3223
Antonio Fernández-DumontEuropean Food Safety Authority (EFSA), Parma, Italy.
Sangeeta KhareNational Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.ORCID 0000-0002-9496-6636
Abelardo MargollesGroup of Functionality and Ecology of Beneficial Microorganisms (MicroHealth), Instituto de Productos Lácteos (IPLA-CSIC), Villaviciosa, Asturias, Spain.ORCID 0000-0003-2278-1816
Ana MárquezInstitute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain.ORCID 0000-0001-9913-7688
Javier MartínInstitute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain.ORCID 0000-0003-0696-505X
Caroline MertenAdministration luxembourgeoise vétérinaire et alimentaire (ALVA), Strassen, Luxembourg.
Antonia MontillaDepartment of Bioactivity and Food Analysis, Instituto de Investigación en Ciencias de la Alimentación (CIAL), CSIC-UAM, CEI (UAM+CSIC), Madrid, Spain.ORCID 0000-0003-2117-6999
Ana Muñoz-LabradorDepartment of Bioactivity and Food Analysis, Instituto de Investigación en Ciencias de la Alimentación (CIAL), CSIC-UAM, CEI (UAM+CSIC), Madrid, Spain.ORCID 0000-0003-0177-0632
Jorge NovoaComputational Systems Biology Group, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.
Cyrielle PayenFrench Agency for Food, Environmental and Occupational Health and Safety, ANSES, Hygiene and Quality of Poultry, Pig Products Unit, Ploufragan, France.
Helen WithersFood Safety and Microbiology, Food Standards Australia New Zealand, Wellington, New Zealand.ORCID 0000-0001-7882-3881
Patricia Ruas-MadiedoGroup of Functionality and Ecology of Beneficial Microorganisms (MicroHealth), Instituto de Productos Lácteos (IPLA-CSIC), Villaviciosa, Asturias, Spain.ORCID 0000-0001-6158-9320
Lorena RuizGroup of Functionality and Ecology of Beneficial Microorganisms (MicroHealth), Instituto de Productos Lácteos (IPLA-CSIC), Villaviciosa, Asturias, Spain.ORCID 0000-0001-8199-5502
Yolanda SanzInstitute of Agrochemistry and Food Technology, Excellence Centre Severo Ochoa, Spanish National Research Council (IATA-CSIC), Valencia, Spain.ORCID 0000-0002-1615-1976
Rodrigo Jiménez-SaizDepartment of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.ORCID 0000-0002-0606-3251
F Javier MorenoDepartment of Bioactivity and Food Analysis, Instituto de Investigación en Ciencias de la Alimentación (CIAL), CSIC-UAM, CEI (UAM+CSIC), Madrid, Spain.ORCID 0000-0002-7637-9542
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
The gut microbiome is indispensable for the host physiological functioning. Yet, the impact of non-nutritious dietary compounds on the human gut microbiota and the role of the gut microbes in their metabolism and potential adverse biological effects have been overlooked. Identifying potential hazards and benefits would contribute to protecting and harnessing the gut microbiome's role in supporting human health. We discuss the evidence on the potential detrimental impact of certain food additives and microplastics on the gut microbiome and human health, with a focus on underlying mechanisms and causality. We provide recommendations for the incorporation of gut microbiome science in food risk assessment and identify the knowledge and tools needed to fill these gaps. The incorporation of gut microbiome endpoints to safety assessments, together with well-established toxicity and mutagenicity studies, might better inform the risk assessment of certain contaminants in food, and/or food additives.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Relevance of gut microbiome research in food safety assessment. · full record | OpenQuestion